Gliomas

Oncology·MeSH: Glioma

8 drugs in development·5 companies·2 clinical trials

Drug Pipeline by Phase

Phase 3(5)

Drug	Company
A10 and AS2-1 Antineoplaston	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
Antineoplastons (A10 & AS2-1)	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
Antineoplastons (A10 and AS2-1)	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
Antineoplastons A10 and AS2-1	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
hmpl-306	HUTCHMED (China) Ltd (HMDCF)

Phase 1(1)

Drug	Company
mb-108	MUSTANG BIO, INC. (MBIO)

Preclinical(1)

Drug	Company
ateganosine	MAIA Biotechnology, Inc. (MAIA)

Phase 4(1)

Drug	Company
Paxalisib	UNITED THERAPEUTICS Corp (UTHR)

BioSniper tracks 8 drugs in development for Gliomas across 5 companies.

There are 2 clinical trials targeting Gliomas tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.